A topical nanoparticulate spironolactone formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/51 (2006.01) A61K 9/06 (2006.01) A61K 31/585 (2006.01) A61K 47/14 (2006.01)

Patent

CA 2509101

The invention relates to a topical nanoparticulate spironolactone formulation comprising nanoparticles having a mean diameter, measured by photon correlation spectroscopy, in the range of from about 300nm to about 900nm. The nanoparticles are incorporated into a crystalline network system comprising a dispersion of solid crystals of polar lipids, said lipids exposing their hydrophilic side outwards and their hydrophobic side inwards towards the spironolactone nanoparticles.

L'invention concerne une préparation topique de spironolactone nanoparticulaire, les nanoparticules ayant un diamètre moyen, mesuré par spectroscopie de corrélation des photons, d'environ 300 nm à 900 nm. Les nanoparticules sont incorporées dans un système de réseau cristallin comprenant une dispersion de cristaux solides de lipides polaires, lesdits lipides exposant leur côté hydrophile à l'extérieur et leur côté hydrophobe à l'intérieur vers les nanoparticules spironolactone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A topical nanoparticulate spironolactone formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A topical nanoparticulate spironolactone formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A topical nanoparticulate spironolactone formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1760099

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.